Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies-Reference-Cited by-同舟云学术

Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies

Published:2017-05 Issue:5 Volume:16 Page:351-359
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Wile Daryl J,Agarwal Pankaj A,Schulzer Michael,Mak Edwin,Dinelle Katherine,Shahinfard Elham,Vafai Nasim,Hasegawa Kazuko,Zhang Jing,McKenzie Jessamyn,Neilson Nicole,Strongosky Audrey,Uitti Ryan J,Guttman Mark,Zabetian Cyrus P,Ding Yu-Shin,Adam Mike,Aasly Jan,Wszolek Zbigniew K,Farrer Matthew,Sossi Vesna,Stoessl A Jon

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference28 articles.

1. Prediagnostic presentations of Parkinson's disease in primary care: a case-control study;Schrag;Lancet Neurol,2015

2. Staging of brain pathology related to sporadic Parkinson's disease;Braak;Neurobiol Aging,2003

3. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice;Luk;Science,2012

4. PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation;Adams;Brain,2005

5. Dopamine turnover increases in asymptomatic LRRK2 mutations carriers;Sossi;Mov Disord,2010

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parkinson’s LRRK2-G2019S risk gene mutation drives sex-specific behavioral and cellular adaptations to chronic variable stress;Frontiers in Behavioral Neuroscience;2024-09-12

2. Reducing the lipase LIPE in mutant α-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism;Neurobiology of Disease;2024-09

3. Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa‐Induced Dyskinesia;Movement Disorders;2024-08-12

4. Concerns with the new biological research criteria for synucleinopathy – Authors' reply;The Lancet Neurology;2024-07

5. Parkinson’s LRRK2-G2019S risk gene mutation drives sex-specific behavioral and cellular adaptations to chronic variable stress;2024-06-08